C. M. Cutillo

Future of Rare Diseases Research 2017–2027: An IRDiRC Perspective

Christine M. Cutillo, S. Terry, C. Austin, 2017, Clinical and translational science.

Machine intelligence in healthcare—perspectives on trustworthiness, explainability, usability, and transparency

Christine M. Cutillo, Karlie R. Sharma, K. Mandl, 2020, npj Digital Medicine.

The IDeaS initiative: pilot study to assess the impact of rare diseases on patients and healthcare systems

M. Haendel, J. Rutter, A. Pariser, 2021, Orphanet Journal of Rare Diseases.

Progress in Rare Diseases Research 2010–2016: An IRDiRC Perspective

Christine M. Cutillo, C. Austin, P. Kaufmann, 2017, Clinical and translational science.

Can you hear us now? The impact of health-care utilization by rare disease patients in the United States

Christine M. Cutillo, C. M. Cutillo, Maharaj Singh, 2021, Genetics in Medicine.

International collaborative actions and transparency to understand, diagnose, and develop therapies for rare diseases

Christine M. Cutillo, C. Austin, K. Boycott, 2019, EMBO molecular medicine.

Machine intelligence in healthcare—perspectives on trustworthiness, explainability, usability, and transparency

Maxine Mackintosh, Christine M. Cutillo, Karlie R. Sharma, 2020, npj Digital Medicine.

A Global Approach to Rare Diseases Research and Orphan Products Development: The International Rare Diseases Research Consortium (IRDiRC).

Christopher P Austin, Christine M. Cutillo, C. Austin, 2017, Advances in experimental medicine and biology.

The importance of international collaboration for rare diseases research: a European perspective

Christine M. Cutillo, C. Austin, A. Rath, 2017, Gene Therapy.